CRIS Q2 2023 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-8.2% YoY

Gross Profit

$2M96.6% margin

Operating Income

-$12M-552.5% margin

Net Income

-$12M-544.4% margin

EPS (Diluted)

$-2.47

QoQ Revenue Growth

-4.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$84M

Total Liabilities

$58M

Stockholders' Equity

$26M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-8.2%
Gross Profit	$2M	$2M	-9.7%
Operating Income	-$12M	-$15M	+19.4%
Net Income	-$12M	-$16M	+25.0%

Revenue Segments

Gross Royalty Revenue

$2M100%